Capricor Therapeutics (CAPR) Divestments (2013 - 2014)

Capricor Therapeutics' (CAPR) quarterly Divestments came in at -$94314.0 in Q1 2014, down 121.88% year-on-year from $431040.0 in Q1 2013, and down 121.88% quarter-over-quarter from $431040.0 in Q1 2013.

Capricor Therapeutics (CAPR) Divestments (2013 - 2014) Analysis & Trends

Capricor Therapeutics' Divestments history runs 2 years deep, the most recent figure standing at -$94314.0 for Q1 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -32.58 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Capricor Therapeutics 1.12 Bn 1.12 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2014 -94,314.00
Mar 31, 2013 431,040.00